Keywords
MedicineMethotrexateInternal medicine
Affiliated Institutions
Related Publications
Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis
Interleukin-6 (IL-6) levels are known to be increased in patients with rheumatoid arthritis (RA). Tocilizumab, a monoclonal antibody to the IL-6 receptor (IL-6R), reduces diseas...
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Abstract Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, mandate regular updating of concepts and management. A European Leuke...
Covariance Analysis of Censored Survival Data
The use of regression models for making covariance adjustments in the comparsion of survival curves is illustrated by application to a clinical trial of maintenance therapy for ...
Oxidant—antioxidant imbalance in blood of children with juvenile rheumatoid arthritis
Abstract Juvenile rheumatoid arthritis (JRA) is the most commonly diagnosed rheumatic disease in children and may represent not a single disease, but rather a syndrome of divers...
Publication Info
- Year
- 2007
- Type
- letter
- Volume
- 66
- Issue
- 11
- Pages
- 1409-1410
- Citations
- 26
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
26
OpenAlex
Cite This
J. W. J. Bijlsma,
M E Weinblatt
(2007).
Optimal use of methotrexate: the advantages of tight control.
Annals of the Rheumatic Diseases
, 66
(11)
, 1409-1410.
https://doi.org/10.1136/ard.2007.076463
Identifiers
- DOI
- 10.1136/ard.2007.076463